Bone Biologics Corp (BBLG)
1.81
+0.05
(+2.84%)
USD |
NASDAQ |
May 08, 16:00
1.69
-0.12
(-6.63%)
Pre-Market: 20:00
Bone Biologics Enterprise Value: -2.060M for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 08, 2024 | -2.060M |
| May 07, 2024 | -2.086M |
| May 06, 2024 | -2.049M |
| May 03, 2024 | -2.038M |
| May 02, 2024 | -2.040M |
| May 01, 2024 | -2.129M |
| April 30, 2024 | -2.192M |
| April 29, 2024 | -2.190M |
| April 26, 2024 | -2.209M |
| April 25, 2024 | -2.215M |
| April 24, 2024 | -2.212M |
| April 23, 2024 | -2.172M |
| April 22, 2024 | -2.172M |
| April 19, 2024 | -2.166M |
| April 18, 2024 | -2.068M |
| April 17, 2024 | -2.081M |
| April 16, 2024 | -2.092M |
| April 15, 2024 | -2.166M |
| April 12, 2024 | -2.130M |
| April 11, 2024 | -2.134M |
| April 10, 2024 | -2.150M |
| April 09, 2024 | -2.118M |
| April 08, 2024 | -2.076M |
| April 05, 2024 | -2.102M |
| April 04, 2024 | -2.070M |
| Date | Value |
|---|---|
| April 03, 2024 | -1.980M |
| April 02, 2024 | -1.958M |
| April 01, 2024 | -1.889M |
| March 28, 2024 | -1.889M |
| March 27, 2024 | -1.937M |
| March 26, 2024 | -1.905M |
| March 25, 2024 | -1.841M |
| March 22, 2024 | -1.825M |
| March 21, 2024 | -1.851M |
| March 20, 2024 | -1.803M |
| March 19, 2024 | -1.744M |
| March 18, 2024 | -1.841M |
| March 15, 2024 | -1.782M |
| March 14, 2024 | -1.694M |
| March 13, 2024 | -1.654M |
| March 12, 2024 | -1.739M |
| March 11, 2024 | -1.659M |
| March 08, 2024 | -1.739M |
| March 07, 2024 | -1.776M |
| March 06, 2024 | -1.779M |
| March 05, 2024 | -1.803M |
| March 04, 2024 | -1.707M |
| March 01, 2024 | -1.728M |
| February 29, 2024 | -1.718M |
| February 28, 2024 | -1.793M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.211M
Minimum
Jun 15 2023
69.19M
Maximum
Nov 01 2021
7.267M
Average
-1.220M
Median
Enterprise Value Benchmarks
| ThermoGenesis Holdings Inc | 9.306M |
| BioVie Inc | 9.318M |
| Krystal Biotech Inc | 3.965B |
| Adial Pharmaceuticals Inc | 3.620M |
| NovaBay Pharmaceuticals Inc | 2.636M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.550M |
| Total Expenses (Quarterly) | 1.16M |
| EPS Diluted (Quarterly) | -2.901 |
| Earnings Yield | -4.23K% |